Related Experiment Video
Updated: Aug 5, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
Diagnosis and management of hypertension in obesity
1Department of Hypertension and Diabetology, Medical University of Gdañsk, Debinki 7c, 80-952 Gdañsk, Poland. knark@amg.gda.pl
Insights
Obesity and hypertension significantly increase cardiovascular risk. Managing this requires assessing global risk factors, not just blood pressure, and considering specific treatments for obese patients.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Cardiovascular risk is amplified in patients with obesity and hypertension due to risk factor clustering.
- Assessing blood pressure and target organ damage can be challenging in obese hypertensive individuals.
- Current guidelines lack specific pharmacological recommendations for hypertension in obese patients.
Purpose of the Study:
- To highlight the importance of global cardiovascular risk assessment in hypertensive patients, especially those with obesity.
- To review challenges and potential therapeutic strategies for managing hypertension in obese individuals.
- To emphasize the need for considering specific conditions like obstructive sleep apnea.
Main Methods:
- Review of current literature and clinical guidelines on hypertension management in obesity.
- Analysis of evidence regarding the impact of different antihypertensive drug classes on obese patients.
- Discussion of diagnostic challenges and differential diagnoses in this population.
Main Results:
- Intensive lifestyle interventions can improve weight, blood pressure, and cardiovascular risk in obese hypertensive patients.
- Beta-blockers and diuretics may increase new-onset diabetes risk compared to other therapies.
- Renin-angiotensin system blockers may offer particular benefits for obese hypertensive patients.
- Obesity complicates hypertension management with poorer treatment response and increased medication needs.
Conclusions:
- Comprehensive cardiovascular risk assessment, beyond blood pressure, is crucial for hypertensive patients with obesity.
- Pharmacological management should consider potential adverse effects (e.g., new-onset diabetes) and specific benefits (e.g., renin-angiotensin system blockers).
- Obstructive sleep apnea should be considered in obese hypertensive patients with poor treatment response.
Abstract:
Cardiovascular risk in a patient with obesity hypertension increases with the extent of risk factor clustering. It is therefore important to determine the global risk of a patient with hypertension rather than to focus solely on blood pressure. Every hypertensive should be screened for other than blood pressure risk factors, target organ damage and concomitant diseases or accompanying clinical conditions. Assessment of blood pressure and target organ damage might be more difficult in obese hypertensives than in normal-weight patients. Intensive lifestyle interventions can reduce weight, and decrease blood pressure and cardiovascular risk in obese hypertensive patients. Current guidelines do not provide specific recommendation for pharmacological management of the hypertensive patients with obesity. Recent trials have consistently shown that therapy involving beta-blockers and diuretics may induce more new-onset diabetes compared with other combination therapies. Several lines of evidence suggest that anti-hypertensive agents that block the renin-angiotensin system may be especially beneficial in treating obese hypertensive patients. Hypertension management in obese individuals is complicated by poorer response to treatment, and the increased need for multiple medications. It is important to consider obstructive sleep apnoea in the differential diagnosis of hypertensive patients who respond poorly to combination therapy with anti-hypertensive medications.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Drug Dosing: Obese Patients
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

